These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3684601)

  • 21. Benzo(a)pyrene metabolism by rat liver microsomes: effects of adding purified glutathione S-transferases A, B, and C.
    Morgenstern R; Guthenberg C; Mannervik B; DePierre JW; Ernster L
    Cancer Res; 1982 Oct; 42(10):4215-21. PubMed ID: 6286104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzo(a)pyrene phenol production by perfused rat liver and its inhibition by ethanol.
    Reinke LA; McManus P; Kauffman FC; Thurman RG
    Cancer Res; 1982 May; 42(5):1681-5. PubMed ID: 6279282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinogenic benzo(a)pyrene metabolites bound to DNA: metabolic formation by human cultured lymphocytes and by human liver microsomes.
    Boobis AR; Atlas SA; Nebert DW
    Pharmacology; 1978; 17(5):241-8. PubMed ID: 704661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro metabolism of benzo(a)pyrene by human liver microsomes and lymphocytes.
    Selkirk JK; Croy RG; Whitlock JP; Gelboin HV
    Cancer Res; 1975 Dec; 35(12):3651-5. PubMed ID: 1192426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rat liver microsomal metabolites of 7-methylbenz[c]acridine.
    Ireland CM; Cheung HT; Ryan AJ; Holder GM
    Chem Biol Interact; 1982 Jul; 40(3):305-18. PubMed ID: 6282474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the DNA intercalative binding of bay versus K region metabolites of benzo[a]pyrene.
    Abramovich M; Zegar IS; Prakash AS; Harvey RG; LeBreton PR
    Prog Clin Biol Res; 1985; 172A():217-25. PubMed ID: 4039443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of cytochrome P-450-448 inhibitors on the binding of benzo(a)pyrene and derivatives to DNA upon microsomal activation.
    Liu WI; Sloane NH
    Xenobiotica; 1979 Mar; 9(3):165-71. PubMed ID: 38576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation of benzo(a)pyrene to microsomal enzymes by asbestos fibers in the Salmonella/mammalian microsome mutagenicity test.
    Szyba K; Lange A
    Environ Health Perspect; 1983 Sep; 51():337-41. PubMed ID: 6315376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme immunoassay of benzo[a]pyrene conjugated to DNA, RNA and microsomal proteins using a monoclonal antibody.
    Wallin H; Borrebaeck CA; Glad C; Mattiasson B; Jergil B
    Cancer Lett; 1984 Mar; 22(2):163-70. PubMed ID: 6200206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific quenching of the fluorescence of benzo (a) pyrene by hepatic microsomes from 3-methylcholanthrene-treated rats.
    Matsuyama A; Kaneko M; Nagata C
    Biochem Biophys Res Commun; 1977 Aug; 77(3):918-24. PubMed ID: 901521
    [No Abstract]   [Full Text] [Related]  

  • 31. Benzo[a]pyrene metabolism in marine fish and some analytical aspects of its metabolites.
    Schoor WP
    Natl Cancer Inst Monogr; 1984 May; 65():391-6. PubMed ID: 6087146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in vitro metabolism and convalent binding of benzo[a]pyrene to DNA catalysed by trout liver microsomes.
    Ahokas JT; Saarni H; Nebert DW; Pelkonen O
    Chem Biol Interact; 1979 Apr; 25(1):103-11. PubMed ID: 466723
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro metabolic conversion of aflatoxins and benzo(alpha)pyrene to nucleic acid-binding metabolites.
    Gurtoo HL; Dave CV
    Cancer Res; 1975 Feb; 35(2):382-9. PubMed ID: 234034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsome-dependent binding of benzo(alpha)pyrene and aflatoxin B1 to DNA, and benzo(alpha)pyrene binding to aflatoxin-conjugated DNA.
    Alexandrov K; Frayssinet C
    Cancer Res; 1974 Dec; 34(12):3289-95. PubMed ID: 4154143
    [No Abstract]   [Full Text] [Related]  

  • 35. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
    Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-pressure liquid chromatography analysis of benzo(a)pyrene metabolism by microsomal enzymes from rhesus liver and lung.
    Hundley SG; Freudenthal RI
    Cancer Res; 1977 Jan; 37(1):244-9. PubMed ID: 401471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of benzo(a)pyrene metabolism in hepatic microsomes from untreated and induced rats by imidazole derivatives which inhibit monooxygenase activity and enhance epoxide hydrolase activity.
    James MO; Little PJ
    Drug Metab Dispos; 1983; 11(4):350-4. PubMed ID: 6137342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prediction of benzo[a]pyrene clearance by rat liver and lung from enzyme kinetic data.
    Wiersma DA; Roth RA
    Mol Pharmacol; 1983 Sep; 24(2):300-8. PubMed ID: 6310365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of inducers and inhibitors of mixed-function oxidasts on benzo(a)pyrene binding to the DNA of rat liver nuclei.
    Alexandrov K; Thompson MH
    Cancer Res; 1977 May; 37(5):1443-9. PubMed ID: 856463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
    Kari FW; Kauffman FC; Thurman RG
    Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.